PETER FACCHINI, PHD

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Enveric Biosciences, Inc.

Filing Date Source Excerpt
2024-12-18 Peter Facchini, PhD (2) Includes 19,720 shares of Common Stock, 5,562 Restricted Stock Units that will vest within 60 days of December 11, 2024, options to purchase 1,994 shares of Common Stock exercisable within 60 days of December 11, 2024, and warrants to purchase 12,227 shares of Common Stock exercisable within 60 days of December 11, 2024.

Data sourced from SEC filings. Last updated: 2026-02-03